Document Detail


The influence of gastroesophageal reflux disease and its treatment on asthmatic cough.
MedLine Citation:
PMID:  15793667     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Gastroesophageal reflux is known to cause chronic cough and is also implicated in worsening of asthma. We conducted a prospective study to examine the clinical significance of gastroesophageal reflux disease (GERD) in asthmatic patients with chronic cough to analyze the temporal relationship between reflux events and coughing and to assess the effect of esomeprazole treatment on respiratory symptoms and lung function in these patients. Asthmatic patients (126) with chronic dry cough were studied. Diagnosis of GERD was based on typical symptoms and the effectiveness of therapeutic test or on pH monitoring. Patients without GERD (negative pH results) consisted of the control group. The results of pH monitoring showed that 64% of cough episodes were related to acid reflux and in 91% of reflux events preceded coughing. Esomeprazole treatment (40 mg/day for 3 months) not only diminished GERD symptoms but also improved asthma outcome Baseline FEV(1) and PEF values increased significantly together with a decrease in symptom scores and the use of rescue medication. In most patients included in the extended part of the study for another 3 months, the dose of inhaled steroids could be reduced with sustained GERD therapy. Our data showing that reflux events preceded coughing in most cases and that treatment of GERD resulted in an improvement in different outcome measures of asthma suggest that GERD worsens asthma, and its treatment is of clinical importance to effectively manage these patients.
Authors:
Csaba Böcskei; Magdolna Viczián; Renáta Böcskei; Ildikó Horváth
Related Documents :
16538107 - The relationship between gastro-oesophageal reflux symptoms and achalasia.
18520187 - Nasal pepsin assay and ph monitoring in chronic rhinosinusitis.
8536537 - Effect of hiatal hernia on esophageal manometry and ph-metry in gastroesophageal reflux...
17019737 - Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or ca...
10579967 - Thalidomide therapy for patients with refractory crohn's disease: an open-label trial.
3490957 - Primary biliary cirrhosis. subclinical inflammatory alveolitis in patients with normal ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Lung     Volume:  183     ISSN:  0341-2040     ISO Abbreviation:  Lung     Publication Date:    2005 Jan-Feb
Date Detail:
Created Date:  2005-03-28     Completed Date:  2005-06-09     Revised Date:  2013-01-07    
Medline Journal Info:
Nlm Unique ID:  7701875     Medline TA:  Lung     Country:  United States    
Other Details:
Languages:  eng     Pagination:  53-62     Citation Subset:  IM    
Affiliation:
Korányi National Institute for TB and Pulmonology, Budapest, Hungary. csbockei@freemail.hu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Ulcer Agents / therapeutic use*
Asthma / complications*,  physiopathology,  prevention & control
Case-Control Studies
Cough / etiology*,  prevention & control
Esomeprazole Sodium / therapeutic use*
Female
Gastroesophageal Reflux / complications*,  drug therapy,  physiopathology
Humans
Hydrogen-Ion Concentration
Male
Monitoring, Physiologic
Prospective Studies
Research Design
Time Factors
Chemical
Reg. No./Substance:
0/Anti-Ulcer Agents; L2C9GWQ43H/Esomeprazole Sodium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small c...
Next Document:  Pharmacological study of oyster mushroom (Pleurotus ostreatus) extract on isolated guinea pig trache...